As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The ...

Add Yahoo as a preferred source to see more of our stories on Google. Ever since the United Nations cultural organization recognized the Haiti and the Dominican Republic’s indigenous cassava flatbread ...

Cassava Sciences is laying off 10 employees—a third of its workforce—as the biotech seeks to conserve cash in the wake of the phase 3 fail of its lead Alzheimer’s disease drug. The RETHINK-ALZ trial ...

Add Yahoo as a preferred source to see more of our stories on Google. You may have noticed more products being sold that contain cassava, a starchy vegetable used in many parts of the world. But a new ...

In our series of letters from African journalists, Ghanaian Elizabeth Ohene considers the call of Uganda's President Yoweri Museveni for people to eat the humble cassava as the price of wheat soars ...

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has ...

The biotech is paying $40 million not to acquire a drug or fund a development program, but to satisfy a regulator. The money is going toward a settlement with the Securities and Exchange Commission.

Small Alzheimer’s disease biotech Cassava Sciences is defending its work after a citizen petition filed with the FDA questioned the scientific integrity of the company's clinical trials for simufilam ...